| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 02/02/2005 | EP1351980A4 Peptides for activation and inhibition of delta pkc |
| 02/02/2005 | EP1268824B1 Promoter sequence of 3-phosphoglycerate kinase gene 1 of rhizopus oryzae and its use |
| 02/02/2005 | EP1242601B1 Trichoderma reesei xylanase |
| 02/02/2005 | EP1221490B1 Recombinant adenoviral vectors and their utilization in the treatment of liver cirrhosis |
| 02/02/2005 | EP1198584B1 Transcription-based gene mapping |
| 02/02/2005 | EP1092040B1 Methods of inhibiting helicobacter pylori |
| 02/02/2005 | EP1078074B1 Mutant lactobacillus bulgaricus strains free from beta-galactoside activity |
| 02/02/2005 | EP1032683B1 Polypeptides having 5-aminolevulinic acid synthase activity and nucleic acids encoding same |
| 02/02/2005 | EP0981610B1 Compositions for treatment of disorders involving programmed cell death |
| 02/02/2005 | EP0948254A4 Cell control used to confirm enzymatic activity |
| 02/02/2005 | EP0761683B1 Protein or polypeptide, process for producing the same, and intermediate compound tehrefor |
| 02/02/2005 | EP0758380B1 A process for separating milk clotting enzymes |
| 02/02/2005 | CN1575363A Oxidizing enzymes in the manufacture of paper materials |
| 02/02/2005 | CN1575300A Telomerase inhibitory peptides and uses thereof |
| 02/02/2005 | CN1575298A Supercritical fluids processing: preparation of protein microparticles and their stabilisation |
| 02/02/2005 | CN1572878A Method for producing L-amino acid |
| 02/02/2005 | CN1572871A Method of maintaining or improving a nitrile hydratase activity |
| 02/02/2005 | CN1187452C Promotor |
| 02/02/2005 | CN1187450C Method for producing transgenic non-human mammal |
| 02/02/2005 | CN1187449C Expression and purification of soluble SARS virus 3CL proteinase |
| 02/02/2005 | CN1187448C 1, 3-propanediol dehydrogenase Mutant |
| 02/02/2005 | CN1187443C Alkaline fungus serine proteinase and its preapring method and application |
| 02/02/2005 | CN1187438C Fungus strain for high yield chitinase and use thereof |
| 02/01/2005 | US6849782 Arabidopsis antisense deoxyhypusine synthase molecule and method of inhibiting deoxyhypusine synthase expression in plants |
| 02/01/2005 | US6849781 Nucleic acid fragments encoding starch synthase isoform V proteins in plants and seeds |
| 02/01/2005 | US6849726 Non-nucleotide containing RNA |
| 02/01/2005 | US6849724 Method for transforming plant, the resultant plant and gene thereof |
| 02/01/2005 | US6849721 Modifications of the VEGF receptor-2 protein and methods of use |
| 02/01/2005 | US6849716 Methods for designing inhibitors of serine/threonine kinases and tyrosine kinases |
| 02/01/2005 | US6849715 Agents useful for inactivation of Ras subfamily proteins |
| 02/01/2005 | US6849593 Bifidogenic peptides |
| 02/01/2005 | US6849448 Pigs and pig cells having an inactivated α 1,3-galactosyl transferase gene |
| 02/01/2005 | US6849443 Human kinases and polynucleotides encoding the same |
| 02/01/2005 | US6849441 Heat resistant enzymatic polypepide; for use as tool in genetic engineering |
| 02/01/2005 | US6849440 Proteases from gram-positive organisms |
| 02/01/2005 | US6849439 Modified barley α-glucosidase |
| 02/01/2005 | US6849438 Isolated and purified human soluble guanylyl cyclase α1/β1 (hsgcα1/β1) |
| 02/01/2005 | US6849437 47153, a human glycosyltransferase family member and uses therefor |
| 02/01/2005 | US6849436 Nucleotide sequences coding polypeptide for use in the treatment of blood disorders, gout, kidney stones, Lesch-Nyhan syndrome, renal failure and uricaciduria |
| 02/01/2005 | US6849435 Use of VLCFAE for identifying herbicidally active compounds |
| 02/01/2005 | US6849434 Ethanol production in recombinant hosts |
| 02/01/2005 | US6849432 Process for producing amide compounds |
| 02/01/2005 | US6849428 Expressing a nucleic acid encoding a fusion protein comprising an intein and a target protein in a host cell, cleaving the intein to generate a cysteine or selenocysteine at the n-terminus target protein |
| 02/01/2005 | US6849421 Nucleotide sequences coding enzymatic polypeptide for the use in the treatment of nervous system disorders |
| 02/01/2005 | US6849420 Isolated autophosphorylating polypeptide, possessing PI3 kinase (phosphoinositide-3 kinase) activity; use drug screening for regulators of cell motility, such as antimetastasis agents |
| 02/01/2005 | US6849395 Gene cluster screening of clones having DNA from mixed populations of organisms |
| 02/01/2005 | US6849257 Comprises catalytic or stoichiometric lipid removal, wherein proteins and/or polypeptides (lysosoymal acid lipase) target receptors in and/or on the cell which lead to uptake into the lysosome |
| 02/01/2005 | CA2436349A1 The selective mmp-9-inhibitor rega-3g12scfv ameliorates in vivo parameters of kidney function after renal ischemia |
| 02/01/2005 | CA2325351C Non-stochastic generation of genetic vaccines and enzymes |
| 01/27/2005 | WO2005007875A2 Enhanced promoters for synthesis of small hairpin rna |
| 01/27/2005 | WO2005007867A2 Thermostable amylase polypeptides, nucleic acids encoding those polypeptides and uses thereof |
| 01/27/2005 | WO2005007864A2 Method for the production of carboxylic acid metal soaps |
| 01/27/2005 | WO2005007857A1 Polypeptide having an improved cytosine deaminase activity |
| 01/27/2005 | WO2005007848A1 Process for producing l-histidine with the use of bacterium belonging to enterobacteriaceae |
| 01/27/2005 | WO2005007847A1 Process for producing l-glutamic acid |
| 01/27/2005 | WO2005007845A2 Transgenic cells |
| 01/27/2005 | WO2005007844A1 Method of screening for agents that modulate immunophilin/peptidylproline cis-trans isomerase (ppiase)-homer interaction |
| 01/27/2005 | WO2005007843A2 Amino acid-substituted coagulation factor v |
| 01/27/2005 | WO2005007842A2 Crystal structure of cdp-me kinase and antimicrobal target |
| 01/27/2005 | WO2005007841A1 Variant serine acetyltransferase and process for producing l-cysteine |
| 01/27/2005 | WO2005007829A2 Materials and methods for the modulation of cyclin-dependent kinase inhibitor-like polypeptides in maize |
| 01/27/2005 | WO2005007826A2 Production of aromatic carotenoids in gram negative bacteria |
| 01/27/2005 | WO2005007820A2 Activated protein c variants with normal cytoprotective activity but reduced anticoagulant activity |
| 01/27/2005 | WO2005007818A2 Exo-specific amylase polypeptides, nucleic acids encoding those polypeptides and uses thereof |
| 01/27/2005 | WO2005007814A2 Genome mapping of functional dna elements and cellular proteins |
| 01/27/2005 | WO2005007813A2 Novel phytase and gene |
| 01/27/2005 | WO2005007690A1 Recombinant expression of streptococcus pyogenes cysteine protease and immunogenic compositions thereof |
| 01/27/2005 | WO2005007624A2 Compositions of orthogonal glutamyl-trna and aminoacyl trna synthetase pairs and uses thereof |
| 01/27/2005 | WO2005007109A2 Methods and compositions for cancer therapy using a novel adenovirus |
| 01/27/2005 | WO2005006864A1 Genetic vaccines for cancer therapy |
| 01/27/2005 | WO2004108754A3 Herpes simplex virus us11 protein and hipk2 protein complexes and uses thereof |
| 01/27/2005 | WO2004099424A3 Enrichment of enzymatic cleavage products |
| 01/27/2005 | WO2004099397A3 Topoisomerase hybrids and methods of use |
| 01/27/2005 | WO2004087046A3 TREATMENT OR PREVENTION OF cGMP-DEPENDENT PATHOPHYSIOLOGY WITH A MUTANT VARIANT OF SOLUBLE GUANYLYL CYCLASE |
| 01/27/2005 | WO2004074499A3 Combinatorial dna library for producing modified n-glycans in lower eukaryotes |
| 01/27/2005 | WO2004072232A3 Covalent tethering of functional groups to proteins |
| 01/27/2005 | WO2004064740A3 Sperm specific lysozyme-like proteins |
| 01/27/2005 | WO2004031730A3 High sensitivity quantitation of peptides by mass spectrometry |
| 01/27/2005 | WO2003100072A3 Method for the production of sulphur-containing fine chemicals by fermentation |
| 01/27/2005 | WO2003087393A3 Human tissue urokinase type plasminogen activator production |
| 01/27/2005 | WO2003087374A9 Derivatives of the il-2 receptor gamma chain, their production and use. |
| 01/27/2005 | WO2003076565A3 Methods of using 46828, a human acyl-coa synthetase |
| 01/27/2005 | WO2003057826A3 SOLUBLE GLcNAC PHOSPHOTRANSFERASE |
| 01/27/2005 | WO2003031594A3 Nucleotide and amino acid sequences relating to respiratory diseases and obesity |
| 01/27/2005 | US20050022270 Expression vector comprising nucleotide sequences coding delta epoxygenase for use in transforming and enhancing fatty acid concentration in plants |
| 01/27/2005 | US20050022269 Expression vector comprising nucleotide sequences coding cartenoid biosynthetic polypeptides for use enhancing cartenoid biosynthesis in darkness |
| 01/27/2005 | US20050022263 DNA and vector for repressing expression of gene of lachrymatory factor-producing enzyme, method for repressing expression of gene of lachrymatory factor-producing enzyme with them and vegetables having repressed expression of gene of lachrymatory factor-producing enzyme |
| 01/27/2005 | US20050020814 Method for renaturating proteins |
| 01/27/2005 | US20050020482 Methods for modulating gap junctions |
| 01/27/2005 | US20050019890 Nitrilase homologs |
| 01/27/2005 | US20050019889 Human osteoclast derived cathepsin |
| 01/27/2005 | US20050019888 Proteases from gram positive organisms |
| 01/27/2005 | US20050019887 Mutant nucleic acid; applying to textiles; mixture with metal compound |
| 01/27/2005 | US20050019886 Generating/designing hydrolase mutants for use in detergents, papermaking and textile treatment |
| 01/27/2005 | US20050019885 Human protein for use in identifying modulator for diagnosis, drug screening, clinical trial monitoring and treatment of metabolic disorders; cosmetics; nutriceutical |
| 01/27/2005 | US20050019882 Using plant enzymes for the production of flavor, fragrance, pharmaceutical or bio-control agents from less valuable substrates; terpenoid biosynthesis |
| 01/27/2005 | US20050019879 Transgenic yeast comprising nucleotide sequences coding L-galactose dehydrogenase (LGDH) for use as enhanced source for generating vitamin c; bioreactor |
| 01/27/2005 | US20050019878 Enzymatic process for the manufacture of l-ascorbic acid and d-erythorbic acid |
| 01/27/2005 | US20050019867 Alpha 1,4-galactosyl transferase and DNA encoding thereof |
| 01/27/2005 | US20050019864 Novel peptide-forming enzyme gene |